
Company valuation, historical trends, and peer comparisons.
According to Arcutis Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.10B. This represents a change of 28.11% compared to the average of 3.20B of the last 4 quarters.
The mean historical Enterprise Value of Arcutis Biotherapeutics, Inc. over the last ten years is 1.13B. The current 4.10B Enterprise Value has changed 262.41% with respect to the historical average. Over the past ten years (40 quarters), ARQT's Enterprise Value was at its highest in in the December 2025 quarter at 3.69B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
1.13B
Median
943.22M
Minimum
20.57M
Maximum
3.66B
Discovering the peaks and valleys of Arcutis Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.55%
Maximum Annual Enterprise Value = 3.66B
Minimum Annual Increase = -64.56%
Minimum Annual Enterprise Value = 20.57M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.66B | 112.17% |
| 2024 | 1.72B | 405.08% |
| 2023 | 341.37M | -64.56% |
| 2022 | 963.38M | -4.07% |
| 2021 | 1.00B | 6.47% |
| 2020 | 943.22M | 22.93% |
| 2019 | 767.31M | 2.23% |
| 2018 | 750.55M | 3.55% |
The current Enterprise Value of Arcutis Biotherapeutics, Inc. (ARQT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.91B
5-year avg
1.54B
10-year avg
1.13B
Arcutis Biotherapeutics, Inc.’s Enterprise Value is greater than Sol-Gel Technologies Ltd. (194.09M), greater than Aclaris Therapeutics, Inc. (553.44M), greater than Turn Therapeutics Inc. (299.97M), greater than Evommune, Inc. (169.10M), greater than Aldeyra The (-11953831.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 194.09M | $209.98M | |
| 553.44M | $572.60M | |
| 299.97M | $304.13M | |
| 169.10M | $221.02M | |
| -11953831.00 | $32.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcutis Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arcutis Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arcutis Biotherapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Arcutis Biotherapeutics, Inc. (ARQT)?
What is the 3-year average Enterprise Value for Arcutis Biotherapeutics, Inc. (ARQT)?
What is the 5-year average Enterprise Value for Arcutis Biotherapeutics, Inc. (ARQT)?
How does the current Enterprise Value for Arcutis Biotherapeutics, Inc. (ARQT) compare to its historical average?